Heska (HSKA) Tops Q2 EPS by 7c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Wall St set for muted open as Middle East tensions curb risk appetite
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Heska Reports Financial Results for the Second Quarter of 2015
July 29, 2015 9:01 AM EDTLOVELAND, Colo., July 29, 2015 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA - News; "Heska" or the "Company"), a provider of advanced veterinary diagnostic and other specialty veterinary products, today reported financial results for its second quarter ended June 30, 2015.
Second Quarter 2015 Highlights with Prior Year Comparison:
Income from Operations was up nearly 100% to $1.829 million, from $917 thousand. Blood Analyzer and Consumables revenue rose 29% to $10.1 million, from $7.8 million. Core Companion Animal revenue was up... MoreHeska Announces Veterinary Market's first and only point of care Analyzer for TSH, Total T4, and Cortisol results in minutes
July 28, 2015 4:21 PM EDTLOVELAND, Colo., July 28, 2015 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA - News; "Heska" or the "Company"), a provider of advanced veterinary diagnostic and other specialty veterinary products, announced today the availability of the new Element i® Immunodiagnostic Analyzer. Element i performs immediate in-clinic testing and screening for key health concerns, including thyroid disorders, Cushing's disease... More
